Johnson & Johnson (JNJ)
Official siteHEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE
Market Cap: $687.89B
Last updated: Nov 17, 2026 at 11:06 AM ET
Johnson & Johnson (JNJ) P/E Ratio & Valuation History
Johnson & Johnson (JNJ) trades at 26.6x trailing earnings and 6.9x sales. Its P/E of 26.6x is above its 5-year median of 16.4x. Its forward P/E is 24.1x. The median P/E across 9 similar companies is 19.9x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 10.4% higher over the next year. Its free cash flow yield is 2.9%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 26.6x |
| Forward P/E | 24.1x |
| Price to sales | 6.9x |
| Price to book | 8.4x |
| EV/EBITDA | 27.3x |
| Price to FCF | 34.1x |
| EV/FCF | 35.5x |
| PEG | 3.2 |
| FCF yield | 2.9% |
Historical Medians
Against its 10-year medians, its P/E is 55.6% above 17.1x, its P/S is 43.8% above 4.8x and its P/B is 44.8% above 5.8x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 26.6x | 16.4x | 17.1x |
| P/S | 6.9x | 5.3x | 4.8x |
| P/B | 8.4x | 5.7x | 5.8x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 14.5x in 2024 to 19.6x in 2020.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $206.95 | 19.2x | 5.3x | 6.2x |
| 2024 | $144.62 | 14.5x | 3.9x | 4.9x |
| 2023 | $156.74 | 15.0x | 4.7x | 5.5x |
| 2022 | $176.65 | 17.4x | 5.8x | 6.1x |
| 2021 | $171.07 | 17.5x | 5.7x | 6.2x |
| 2020 | $157.38 | 19.6x | 5.0x | 6.6x |
| 2019 | $145.87 | 16.8x | 4.7x | 6.5x |
| 2018 | $129.05 | 15.8x | 4.3x | 5.9x |
| 2017 | $139.72 | 19.1x | 4.9x | 6.2x |
| 2016 | $115.21 | 17.2x | 4.4x | 4.5x |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About JNJ
What is JNJ's forward P/E ratio?
Johnson & Johnson has a forward P/E ratio of 24.1x.
Is JNJ stock overvalued?
GNG's valuation label for JNJ is Fairly valued. Its P/E of 26.6x compares with a median of 19.9x across 9 similar companies.
What is JNJ's price to sales ratio?
Johnson & Johnson has a price to sales ratio of 6.9x.
What is Johnson & Johnson's average P/E ratio over 5 years?
Johnson & Johnson's median P/E over the last 5 years is 16.4x, from 60 month-end values through Oct 2026.
What is JNJ's PEG ratio?
Johnson & Johnson has a PEG ratio of 3.2.
JNJ pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts